Glutathione S-transferase Polymorphisms and Bone Tumor Risk in China

Lu, Xiao-Feng;Yang, Wei-Liang;Wang, Zhen-Hai;Li, Jia;Bi, Zheng-Gang

  • Published : 20111200

Abstract

Aim: We aimed to study the potential role of GSTM1 and GSTT1 in the risk of osteosarcoma in Chinese population. Methods: We collected 110 osteosarcomas by pathologic examination and 226 controls from the First Affiliated Hospital of Harbin Medical University during December 2008 to December 2010. Genotyping was based upon duplex polymerase-chain-reaction with the PCR-CTPP method. Results: Individuals carrying null GSTM1 and GSTT1 had 1.50 and 2.07 fold risks of osteosarcoma when compared with non-null genotypes, respectively. The increased risk associated with the GSTT1 polymorphism seemed more evident among males (Null GSTT1 genotype vs. non-null genotype, adjusted OR= 2.43, 95% CI: 1.29-3.30) than females (adjusted OR =1.66, 95% CI: 1.02-2.78). The increased risk was also more evident among individuals aged 15 years or less (adjusted OR for null GSTT1 genotype vs. non-null genotype = 2.24, 95% CI: 1.20-3.24) than those aged more than 15 years (adjusted OR = 1.82, 95% CI: 1.07-2.95). Conclusion: Our study of the association between polymorphisms in GSTM1 and GSTTI and the risk of osteosarcoma in a Chinese population provided evidence that null GSTTI might be a useful marker of susceptibility to osteosarcoma development, especially for male sand young age individuals.

Keywords

References

  1. American Cancer Society (2007). Global Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society. Available at: http://www.cancer.org/downloads/STT/Global_Cancer_Facts_and_Figures_2007_rev.pdf. Oct. 2011.
  2. Barnette P, Scholl R, Blandford M, et al (2004). High-throughput detection of glutathione S-transferase polymorphic alleles in a pediatric cancer population. Cancer Epidemiol Biomarkers Prev, 13, 304-13. https://doi.org/10.1158/1055-9965.EPI-03-0178
  3. Hosgood HD, Berndt SI, Lan Q (2007). GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. Mutat Res, 636, 134-43. https://doi.org/10.1016/j.mrrev.2007.02.002
  4. Ntais C, Polycarpou A, Ioannidis JP (2005). Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 176-81.
  5. Ries LAG, Melbert D, Krapcho M, et al (2009). SEER Cancer Statistics Review, 1975-2004, Based on November 2006 SEER Data Submission. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2004/; Accessed Oct. 2011.
  6. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomark Prev, 6, 733-43.
  7. Saadat M (2006). Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci, 97, 505-9. https://doi.org/10.1111/j.1349-7006.2006.00207.x
  8. Salinas-Souza C, Petrilli AS, de Toledo SR (2010). Glutathione S-transferase polymorphisms in osteosarcoma patients. Pharmacogenet Genomics, 20, 507-15. https://doi.org/10.1097/FPC.0b013e32833caa45
  9. Schneider J, Bernges U, Philipp M, Woitowitz HJ (2004). GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett, 208, 65-74. https://doi.org/10.1016/j.canlet.2004.01.002
  10. Shi X, Zhou S, Wang Z, Zhou Z, Wang Z (2008). CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer, 59, 155-63. https://doi.org/10.1016/j.lungcan.2007.08.004
  11. Sull JW, Ohrr H, Kang DR, Nam CM (2004). Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. Yonsei Med J, 45, 683-9.
  12. U.S. Cancer Statistics Working Group (2009). United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. Available at: http://www.cdc.gov/cancer/npcr/npcrpdfs/US_Cancer_Statistics_2004_Incidence_and_Mortality.pdf. Oct. 2011.
  13. Vogl FD, Taioli E, Maugard C, et al (2004). Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev, 13, 1473-9.
  14. Yang CX, Matsuo K, Wang ZM, Tajima K (2005). Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol, 11, 2531-8.